covaxin – Lawcutor

Phase II, III trials of Covaxin on volunteers aged 2-18 years, challenged : Delhi HC

The Phase II & III clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI), for in the age group of 2…

Centre increases gap between two doses of Covishield to 12-16 weeks

The gap between the first and second doses of the Covishield COVID-19 vaccine has been increased to 12-16 weeks - from the existing six-eight weeks - the government said. The…

Rs 250 for one dose of Covid vaccine

Government said that private hospitals can charge upto Rs.250 maximum for one dose of corona vaccine. While the vaccine is being given free of cost at the government centres, people…

Covaxin’s 20,000 doses arrive Bengaluru, to be used side by side with Covishield

14 Jan 202114 Jan 2021

Since January 12, Bengaluru had already received 8 lakh doses of Covishield from Pune based Serum Institute of India .The main cluster of Covaxin from Hyderabad-based Bharat Biotech of 20,000…

DCGI Approves Serum Institute’s ‘Covishield’ , Bharat Biotech ‘Covaxin’ Vaccines for Emergency Restricted Use

India's drug controller Drugs Controller General of India(DCGI) has approved Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' for restricted emergency use. This was informed by Dr VG Somani,…

Covid-19 vaccine: Dry run in Punjab, Assam, Andhra Pradesh and Gujarat

The exercise of dry run vaccine will continue for two days, December 28 and 29, in two districts each. There will be no vaccine involved in the process, which will…

Covaxin activates immune responses, no side effects: Bharat Biotech

As per the information available in the research paper published by a Hyderabad based firm, the Bharat Biotech Covid vaccine is in the late stage clinical trials and haven't shown…

Bharat Biotech to launch Covaxin by 2021 after approval

Pharmaceutical Company Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities. The…

Phase-1 of clinical trial for Covaxin begins at AIIMS

On Friday, a 30 year old man was administered the first dose of India's indigenous COVID vaccine. He became the first person to test the Bharat Biotech's Covaxin at AIIMS,…